Psyence Biomedical Ltd. Warrant
Market Cap
$1.28K
P/E Ratio
—
EPS
—
Dividend Yield
0.00%
52-Week Range
$0.02 — $0.02
Volume
761
Avg Volume
38.00K
Beta
—
P/E (TTM)
—
Forward P/E
—
PEG Ratio
-0.06
P/S (TTM)
0.00
P/B (TTM)
0.31
P/FCF
—
EV/EBITDA
—
EV/Sales
—
ROE (TTM)
-0.12%
ROA (TTM)
-0.05%
ROIC
—
Gross Margin
0.00%
Operating Margin
0.00%
Net Margin
—
Debt/Equity
0.00
Current Ratio
8.09
EPS Growth (YoY)
—
Revenue Growth (YoY)
—
EPS Growth (3Y)
-4.53%
EPS Growth (5Y)
-2.72%
Sales Growth (3Y)
+0.00%
Sales Growth (5Y)
+0.00%
EPS Est (This Year)
—
EPS Est (Next Year)
—
Dividend Yield
—
Annual Dividend
—
Payout Ratio
—
Frequency
—
Ex-Dividend Date
—
Cash/Share
$4.86
Institutional %
—
Inst. Net Change
—
Insider Net Shares (90d)
—
Outstanding Shares
71.27K
Float
70.98K
Free Float %
99.59%
Sector
Healthcare
Industry
Biotechnology
Country
CA
Exchange
NASDAQ
IPO Date
—
Employees
—
CEO
Jody Aufrichtig
Index Membership
—
Website
https://www.psyencebiomed.com
Psyence Biomedical Ltd. Warrant (PBMWW) is a healthcare company in the biotechnology industry listed on the NASDAQ. With a market capitalization of $1.28K, PBMWW is tracked by stockscreenr alongside 25,000+ other tickers. Use the free stock screener to compare PBMWW against other stocks using dozens of fundamental and technical filters.
No, Psyence Biomedical Ltd. Warrant (PBMWW) does not currently pay a regular dividend. The company may be reinvesting profits into growth, research, or debt reduction instead of returning cash to shareholders through dividends.
Psyence Biomedical Ltd. Warrant (PBMWW) has a market capitalization of $1,283, classifying it as a micro-cap company. Market cap is calculated by multiplying the current share price by the total number of outstanding shares.